Pituitary adenomas: factors in treatment.
D000172:Acromegaly / Q000209:etiology / Q000628:therapy; D000236:Adenoma / Q000601:surgery*; D000239:Adenoma, Acidophil / Q000601:surgery*; D000238:Adenoma, Chromophobe / Q000601:surgery*; D000293:Adolescent; D000309:Adrenal Insufficiency / Q000517:prevention & control; D000328:Adult; D000367:Age Factors; D000368:Aged; D002555:Cerebrospinal Fluid; D003480:Cushing Syndrome / Q000209:etiology; D003907:Dexamethasone / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000209:etiology; D005132:Eye Manifestations; D005260:Female; D005402:Fistula; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007016:Hypophysectomy / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010911:Pituitary Neoplasms / Q000150:complications / Q000175:diagnosis / Q000532:radiotherapy / Q000601:surgery*; D013927:Thrombosis; D013997:Time Factors
D003907:Dexamethasone; D006854:Hydrocortisone